Drawing for MYMARK

USPTO serial 88518725

MYMARK

Reviewed by CopyMark Law Group

Reg. 6049584Status 700Renewal
Filing date
Status date
Registration date
May 5, 2020
Examiner
COHEN, ROBERT ANDREW
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with MYMARK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $1,295*

Plus Government fees of $2,125

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Matthew H Platt

10 E. 39TH STREET, 10TH FLOORC/O SCANBUY, INC.NYC, NY 10016

Goods and services

ClassDescriptionStatusFirst use
005Medical diagnostic kits for taking and storing at-home culture sampling that are used for the ordering of direct-to-consumer laboratory tests for various medical conditions containing medical diagnostic reagents and also plastic storage receptacles; medical test kits primarily composed of medical diagnostic reagents and also alcohol pads for sterilizing fingers, finger-pricks for medical purposes, medical antigens, cotton sticks for medical purposes, medical adhesive tape, bandages for dressings, plastic storage receptacles specially adapted for the safe-transport of culture samples, and printed materials in the nature of instructions and mailing envelopes for testing the presence of medical conditions; medical test kits, featuring medical diagnostic reagents for monitoring various medical conditions and levels of substances, namely, cholesterol, thyroid, vitamins, hormones, kidney and liver functions; medical test kits featuring medical diagnostic reagents for monitoring various relevant medical markers, namely, STDs, cancer, genetic disorders, fertility-related hormone levels, and other laboratory testable blood markers; medical cancer screening kits featuring medical diagnostic reagents for detecting levels of prostate-specific antigens and the PapillomavirusACTIVEOct 23, 2019
009Direct-to-consumer test kits containing laboratory research instruments, namely, pipette tips and inoculation loops, for taking samples for review for various medical conditions for research purposesACTIVEOct 23, 2019
010Direct-to-consumer test kits containing medical instruments for taking samples for review for various medical conditions; medical diagnostic testing kits containing sterile medical specimen collection tools in the nature of lancets, swabs, saliva collection tubes, and collection cards for the collection of blood, urine, saliva, and feces for use in testing and for monitoring various medical conditions, and also including instructions and return shipping packagingACTIVEOct 23, 2019
042Medical and scientific research for providing information regarding results of testing for various medical conditions; providing scientific analysis and information regarding the results of laboratory testing in the field of various medical conditions; providing medical research information regarding results of testing for various medical conditionsACTIVEOct 23, 2019
044Medical services; reporting of information regarding results of testing for various medical conditions directly to the patient; health care services, namely, ordering and review of medical lab testing; medical diagnostic testing, monitoring, and reporting services; medical diagnostic testing for genetic anomalies and disorders, namely, collecting biological samples for laboratory testing for medical purposes, providing laboratory testing and diagnostic services thereto for medical purposes; medical information services, namely, reporting clinical test results to customers via secured mobile platformACTIVEOct 23, 2019

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
May 5, 2025REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
May 5, 2020R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 31, 2020SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 30, 2020CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Mar 17, 2020SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Mar 13, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Feb 24, 2020IUAFUSE AMENDMENT FILED—
Feb 24, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Feb 24, 2020TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Feb 24, 2020CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Feb 24, 2020ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 24, 2020REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Feb 24, 2020COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 28, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Dec 3, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Dec 3, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Nov 13, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Oct 30, 2019ALIEASSIGNED TO LIE—
Oct 23, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Oct 23, 2019XAECEXAMINER'S AMENDMENT ENTERED—
Oct 23, 2019GNENNOTIFICATION OF EXAMINERS AMENDMENT E-MAILED—
Oct 23, 2019GNEAEXAMINERS AMENDMENT E-MAILED—
Oct 23, 2019CNEAEXAMINERS AMENDMENT -WRITTEN—
Oct 10, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 10, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 10, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Oct 3, 2019DOCKASSIGNED TO EXAMINER—
Jul 23, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 20, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance